![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » TAP ENTERS INTO CO-PROMOTION AGREEMENT FOR FAMVIR
TAP ENTERS INTO CO-PROMOTION AGREEMENT FOR FAMVIR
TAP Pharmaceutical Products Inc. announced that it has entered into a co-promotion agreement with Novartis Pharmaceuticals Corporation to co-promote Famvi (famciclovir), an oral antiviral prescription medication. Under the terms of the agreement, TAP will be responsible for promoting Famvir to the Obstetrician/Gynecology (OB/GYN) medical community.
Genetic Engineering News (http://www.genengnews.com/news/bnitem.aspx?name=6241549)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
11Jul
-
18Jul
-
21Oct